Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Novel markers determine the cause of obstructive cholestasis

This week's Annals of Internal Medicine investigates the diagnostic potential of serum and biliary markers in obstructive cholestasis.

News image

fiogf49gjkf04

Cholangiocarcinoma cells express and secrete insulin-like growth factor I and vascular endothelial growth factor.

Dr Domenico Alvaro and colleagues from Italy measured insulin-like growth factor-I and vascular endothelial growth factor in bile and serum of patients with extrahepatic cholangiocarcinoma to evaluate their performance as diagnostic markers.

Biliary insulin-like growth factor-I was 15- to 20-fold higher with extrahepatic cholangiocarcinoma
Annals of Internal Medicine

The team conducted a cross-sectional study with 73 inpatients who consecutively had endoscopic retrograde cholangiopancreatography (ERCP).

The team reported that 29 patients had extrahepatic cholangiocarcinoma, 19 had pancreatic cancer, and 25 had benign biliary abnormalities.

Diagnosis was based on conventional radiology, ERCP, and follow-up.

Insulin-like growth factor I and vascular endothelial growth factor were measured by using enzyme-linked immunosorbent assay.

The research team found that the biliary insulin-like growth factor-I concentration was 15- to 20-fold higher in extrahepatic cholangiocarcinoma than in pancreatic cancer.

The biliary insulin-like growth factor-I concentration was also 15- to 20-fold higher in extra hepatic cholangiocarcinoma than in benign biliary abnormalities.

The area under the receiver-operating characteristic curve was 1 when biliary insulin-like growth factor-I values in the extrahepatic cholangiocarcinoma were compared with benign biliary abnormalities or pancreatic cancer.

The researchers found that, in contrast, biliary vascular endothelial growth factor concentration was similar in the 3 groups.

Serum insulin-like growth factor-I levels were similar among the groups.

The team observed that serum vascular endothelial growth factor levels were higher in the cholangiocarcinoma, and pancreatic cancer groups.

The team noted limitations of the study, reporting that data were obtained in a small sample from a single center, and few patients had a tissue diagnosis.

Dr Alvaro's team concluded, "Biliary insulin-like growth factor-I levels in patients undergoing ERCP for biliary obstruction may differentiate extrahepatic cholangiocarcinoma from either pancreatic cancer or benign biliary abnormalities."

Ann Int Med 2007: 147(7): 451-9
09 October 2007

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us